Drug ID: 1d00000112
Drug Name: Antivenom
Generic Names: Rattlesnake Antivenin
Legal Status: Non Opioid Prescription only drug
Indication for Mother: Category C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Recommended Dose: The recommended initial dose is 5 to 10 mL to infuse over a 3- to 5-minute period.
Recommended In: This medication is an antitoxin, prescribed for the treatment of envenomation caused by bites of crotalids (pit vipers).
Directions For Use: It comes as a solution for injection to be administered by a healthcare provider into the vein.
Storage: Store original, unused (not reconstituted) vials at temperatures not exceeding 98°F (37°C) -Do not freeze.
Dosage Forms: Intravenous injection
Side Effects: Flushing, itching, hives, swelling of the face, tongue, and throat, cough, difficulty in breathing, cyanosis, vomiting and collapse.
In Case of Overdose: No information available yet.
Avoid If: Caution needed for patient with allergy.
Drug Interaction: Therapy with beta-adrenergic blockers, including cardioselective agents, has been associated with an increased severity of acute anaphylaxis.
Anaphylaxis may be prolonged and resistant to conventional treatment in patients receiving beta-adrenergic blockers. The pharmacotherapeutic actions of epinephrine and other adrenergic agents may be altered, and larger than usual doses may be required.